Inhibitor Therapeutics (INTI) SEC Filings & 10K Form $0.07 0.00 (0.00%) (As of 11/21/2024 ET) Add Compare Share Share SEC Filings Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Recent Inhibitor Therapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView11/12/20245:27 AMInhibitor Therapeutics, Inc. (Filer)Inhibitor Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 08/06/20248:30 AMInhibitor Therapeutics, Inc. (Filer)Inhibitor Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 05/16/202412:34 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)Jerman Michael Allen (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/16/202412:34 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)OSMAN RONALD E (Reporting)Ronald E Osman Irrevocable Trust III (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/16/202412:34 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)SEARS SAMUEL P JR (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/16/202412:34 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)MCNULTY JAMES A (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/16/202412:34 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)Yanez Michelle (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/13/20248:00 AMInhibitor Therapeutics, Inc. (Filer)Inhibitor Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 12/14/20235:02 AMInhibitor Therapeutics, Inc. (Filer)Inhibitor Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies CUE 10Q Form JATT 10Q Form DTIL 10Q Form ITRM 10Q Form STTK 10Q Form PVCT 10Q Form TARA 10Q Form ACAB 10Q Form DBVT 10Q Form CALC 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (OTCMKTS:INTI) was last updated on 11/22/2024 by MarketBeat.com Staff From Our PartnersFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s First Warning: 'Boneheads' at the Fed Could Drain Your WealthTrump is Back, but The FED is still coming for Your Wallet. While he’s pushing for America’s growth, the F...All American Assets | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredAmerica’s Pro-Crypto AgendaCash In On the Pro-Crypto America 27 experts reveal their top picks for 2025 Crypto 101 Media | SponsoredA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibitor Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibitor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
